Status:

UNKNOWN

Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma

Lead Sponsor:

Hadassah Medical Organization

Conditions:

Hyperparathyroidism

Eligibility:

All Genders

18-80 years

Brief Summary

The purpose of the study is to determine a possible input of C11-Choline PET/CT in identification and localization of a parathyroid adenoma (PTA). Preoperative localization of a PTA has been previous...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Elevation of a calcium and parathyroid hormone in the serum

Exclusion

    Key Trial Info

    Start Date :

    January 1 2011

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    Estimated Enrollment :

    100 Patients enrolled

    Trial Details

    Trial ID

    NCT01221896

    Start Date

    January 1 2011

    Last Update

    October 15 2010

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hadassah Hebrew University Medical Center

    Jerusalem, Israel, 91120

    Input of C11-Choline PET/CT in Localization of Parathyroid Adenoma | DecenTrialz